]

Journey Colab in the News

September 28, 2022

Journey Colab's work featured in Nature

October 6, 2022

Journey CEO on Psychedelics as Therapy at Aspen Ideas

STAT First Opinion: Working with Indigenous allies is the ethical way to develop psychedelic-based pharmaceuticals

Journey Colab Announces Appointment of Joel A. Posener, MD as Chief Medical Officer

The Burgeoning Psychedelics Industry Is Full of Money and Good Intentions. But Can It Avoid All Of Cannabis's Mistakes?

Forbes: Mental Health Startup Journey Colab Aims To Develop Mescaline As An FDA-Approved Treatment For Alcohol Use Disorder

February 14, 2022

Meet the 16 Most Influential Women Shaping the Future of Psychedelics